This site is intended for healthcare professionals
Innovations in MS care to improve individual disease management

COVID-19 and MS

Read time: 30 mins
Last updated:2nd Sep 2021
Published:11th Nov 2020

Watch the following expert videos to:

  • Catch up on the MSVirtual2020 Biogen-sponsored Satellite Symposium ‘COVID-19 and MS: Lessons (to be) learned from the pandemic’
  • Discover a wide range of perspectives on the lessons learned from the COVID-19 pandemic and the lessons we can still learn

MSVirtual2020 brought together neurologists from around the world for the 8th Joint ACTRIMS-ECTRIMS Meeting. Watch video footage from the Biogen Satellite Symposium ‘COVID-19 and MS: Lessons (to be) learned from the pandemic’ below, featuring relevant insights from Professors Burioni, Peeters and Montalban.

What happens when COVID-19 meets the flu season? A virologist perspective

To gain insight into the impact of the COVID-19 pandemic and its interaction with the upcoming flu season, watch these 3 videos with Professor Roberto Burioni.

The impact of the ongoing COVID-19 pandemic has inspired an enormous level of research into the novel and complex characteristics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Given its differences with other respiratory viruses, assumptions should be avoided.

Comparing SARS-CoV-2 and influenza virus


SARS-CoV-2 pneumonia is very different from anything else known before. There are various key differences between SARS-CoV-2 and SARS-CoV and MERS-CoV as well as with influenza viruses, particularly with regard to the timing of symptom onset and infectivity.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

How did MS patients do with COVID-19? A data scientist perspective

Watch these 5 videos to find out how the MS Global Data Sharing Initiative is collecting data to help answer urgent questions around the management of MS with Professor Liesbet Peeters.

The analysis of ‘big data’ can provide insights for making better informed decisions. The following videos discuss how data from multiple global sources have been collected into an international database and now providing information on the outcomes for people with multiple sclerosis (MS) who have COVID-19.

COVID-19 and the MS Global Data Sharing Initiative


The mission of the MS Global Data Sharing Initiative is to provide answers to urgent questions related to the risk factors for SARS-CoV-2 infection in people with MS. The initiative was designed to scale up COVID-19 data collection, share insights on the effect of COVID-19, and stimulate ongoing research.

How does the Global Data Sharing Initiative work?


The Global Data Sharing Initiative identified a minimal data set common across many different registries and cohorts. The initiative also developed a platform and data sharing pipeline to bring together data from clinicians, people with MS, registries, and data cohorts from across the world.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Will COVID-19 change the way we manage MS? A neurologist perspective

To discover how the COVID-19 pandemic has changed how we manage multiple sclerosis (MS), watch the following 5 videos with Professor Xavier Montalban.

The COVID-19 pandemic has had a huge impact in countries around the world. Notably, it has required healthcare professionals to adapt and utilise new technologies to manage MS patients. It also led to many questions about MS treatment decision making. These changes may have long lasting effects. The following videos address the question, will COVID-19 change the way we manage MS forever?

The impact of COVID-19


The COVID-19 lockdown majorly impacted mobility patterns in Spain. Societal changes were evident in google reports and showed how striking the effects of the “stay at home” order in Spain were. COVID-19 also affected the healthcare system, individual MS patients and the treatment of MS.

Adapting to the COVID-19 pandemic


Adapting to COVID-19 required using digital communication at many levels. Telemedicine was instituted not only for individual patient consultations, but also for group rehabilitation and psychological support. Logistical changes at the Cemcat included home infusion of selected patients and DMT deliveries.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Welcome: